Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 ...

As well as shedding pounds and controlling diabetes, Ozempic and Wegovy can help you drink less, researchers suggest ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...

Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy ... Some 12% of US adults have tried a GLP-1 agonist for either ...